RBRuben Dario Vasquez Becerra

Ruben Dario Vasquez Becerra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ruben Dario Vasquez Becerra has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Coinfección viral con SARS-CoV2 en pacientes peruanos hospitalizados durante los años 2020-2021

    by Carlos Augusto Yabar, Karolyn Vega-Chozo, Eduardo Miranda-Ulloa, Flor de María Peceros-Pelaez, Manuel Terrazas-Aranibar, Adolfo Marcelo, María Paquita García, María Elena López, Rubén Vásquez, Katia Zúñiga, et al.

    El estudio tuvo como objetivo identificar las coinfecciones de SARS-CoV-2 con otros virus en pacientes con COVID-19 moderada y grave. Se seleccionaron 98 pacientes de Lima, San Martín y Loreto, a quienes se tomaron muestras de secreción nasofaríngea, sangre y orina analizadas mediante pruebas serológicas y moleculares para detectar HTLV, VIH, hepatitis B, dengue, Chikungunya, Zika y un panel de virus respiratorios (influenza A/B, rinovirus, virus respiratorio sincitial, metaneumovirus y adenovirus). Los resultados mostraron dos casos de coinfección (2/98; 2%): uno con SARS-CoV-2/rinovirus y otro con SARS-CoV-2/HTLV-2. Ambos pacientes presentaron neumonía asociada a COVID-19, pero evolucionaron favorablemente. Se concluye que la frecuencia de coinfección viral en pacientes de establecimientos de salud de la costa y selva peruana con cuadros moderados y graves de COVID-19 fue baja.

  • HIV treatment cascade in regions of Peru with the highest HIV prevalence

    by Nora Reyes, Carlos Benites, Lisset García‐Fernández, Maria Calderon, Fabián Fiestas, Ruben Vasquez‐Becerra, Eva Aranda, Carlos A. Yabar, Angélica García, Cesar Ramal, et al.

    Objectives: To describe the HIV treatment cascade and care continuum in regions of highest HIV prevalence in Peru.Methods: An observational longitudinal study was carried out in 14 tertiary hospitals in Peru. These are the main hospitals that administer antiretroviral treatment (ART) in the regions that represent approximately 95% of reports of HIV/AIDS cases in Peru in 2013. We included individuals older than 18 years newly diagnosed with HIV from 1 January 2011 to 31 December 2012. Medical records were reviewed until 2015.Results: A total of 2119 people living with HIV (PLHIV) were identified in the selected health facilities (mean age = 35.26 years, 78% male). 97.25% [1845/1897; 95% confidence interval (CI): 96.4–97.9%] of the patients attended the consultation at least once during the follow‐up, but only 64.84% (885/1365; 95% CI: 62.2–67.4%) attended within a month after the diagnosis. After starting ART, 74.63% (95% CI: 71.9–77.2%) of PLHIV remained in healthcare. Regardless of the time after diagnosis, 88.40% (1837/2078; 95% CI: 86.9–89.7%) of PLHIV started ART during the observation time. However, 78.68% (95% CI: 76.8–80.4%) did so during the first post‐treatment year and only 28.88% (95% CI: 27.9–31.9%) after 1 month. After starting treatment, it was observed that 51.60% (95% CI: 49.2–54%) of PLHIV reached viral suppression during the follow‐up period.Conclusions: Further analysis and improvements in the definition of indicators are required to achieve conclusive results; however, these data will give us a general understanding of the progress of Peruvian health policies in achieving the goal established by the WHO.


  • Open Access

    Discutiendo estrategias para la continuidad en la atención de PVV en el contexto de la pandemia por SARS CoV 2

    by Ruben Dario Vasquez Becerra, Ana Vera, Rosa Terán, Carlos Benites